Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$136M
3 rounds on record
Latest round
$45M
Venture round · Feb 2024 · 2 yr ago
Team
201-500
employees, estimated range
Backers
2
OrbiMed, Pontifax
The money's age
Long since its last round
31 months since the last round · not hiring
Momentum
0/100
no fresh signals
Funding rounds
RoundDateAmountInvestorsSource
Venture round Feb 2024 $45M — SEC Form D
Venture round Aug 2021 $85M — SEC Form D
Venture round Sep 2019 $6M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity VANQUA BIO, INC. sec
Founders and leadersfrom filings, registers and the company's site
Viola MeehanExecutive OfficerSEC Form D
James SullivanExecutive Officer, DirectorSEC Form D
Jonathan SilversteinDirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
Brenig Therapeutics develops innovative small-molecule therapies for neurodegenerative diseases, including LRRK2 inhibitors targeting…
VectoryTxFounded 2020 • 51-200 employees
A biotech company dedicated to developing transformative medicines for people with neurodegenerative diseases using cutting-edge science…
Samsara TherapeuticsVenture round $10.3M · 5 yr ago • Founded 2018 • 11-50 employees
We are on a mission to unlock the full potential of autophagy activation in combating age-related neurodegenerative diseases.
Monument BiosciencesVenture round $5.8M · 3 yr ago • Founded 2018 • 11-50 employees
Boldly advancing the next generation of medicines for Alzheimer’s Disease and Related Dementias.
NeuravaVenture round $1.6M · 11 mo ago • Founded 2019 • 11-50 employees
Giving back control to patients with uncontrolled epilepsy. At Neurava, we empower individuals with epilepsy to reclaim their lives with…
Advancing Accessible Solutions for Complex Neurodegenerative Diseases. Protecting neurons to advance treatment for neurodegenerative…

Overview

Our Mission. Deliver medicines that transform the lives of patients with neurodegenerative diseases.

People

Viola Meehan
Executive Officer
James Sullivan
Executive Officer, Director
Jonathan Silverstein
Director
Mona Ashiya
Director
Bernard Davitian
Director
Sara Nayeem
Director
Stephen Squinto
Director
Rand Sutherland
Director
Uya Chuluunbaatar
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Chicago United States
HQ
200-500 est. staff

Financials

Total raised
$136M
Latest round
Venture - Series Unknown
Funding rounds
3
Funding rounds
Round Announced Amount
Venture - Series Unknown 2024 $45M Details
Venture - Series Unknown 2021 $85M Details
Venture - Series Unknown 2019 $6M Details